CN1294980C - Medicine for treating liver disease - Google Patents

Medicine for treating liver disease Download PDF

Info

Publication number
CN1294980C
CN1294980C CNB2004100547217A CN200410054721A CN1294980C CN 1294980 C CN1294980 C CN 1294980C CN B2004100547217 A CNB2004100547217 A CN B2004100547217A CN 200410054721 A CN200410054721 A CN 200410054721A CN 1294980 C CN1294980 C CN 1294980C
Authority
CN
China
Prior art keywords
radix
rhizoma
fructus
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2004100547217A
Other languages
Chinese (zh)
Other versions
CN1586512A (en
Inventor
殷贵森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2004100547217A priority Critical patent/CN1294980C/en
Publication of CN1586512A publication Critical patent/CN1586512A/en
Application granted granted Critical
Publication of CN1294980C publication Critical patent/CN1294980C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to high efficiency liver restoring powder which a medicine composition for treating hepatitis. The present invention is prepared from the following raw materials of 10 to 20 of bupleurum root, 5 to 15 of longflower stringbush flower, 10 to 20 of red peony root, 4 to 8 of Chinese asafoetida, 5 to 15 of green tangerine peel, 6 to 12 of shigu, 10 to 20 of officinal magnolia bark, 10 to 20 of common prism rhizome, 5 to 15 of zedoary, 10 to 20 of tsaoko, 10 to 20 of heterophylly falsestarwort root, 10 to 20 of largehead atractylodesrhizome, 10 to 20 of tuckahoe, 3 to 7 of costus root, 10 to 20 of curcuma root, 15 to 25 of areca peel, 10 to 20 of turtle shell, 5 to 15 of leech, 5 to 15 of angelica, 2 to 4 of ganoderma, 15 to 30 of Chinese lobelia herb, 3 to 9 of safflower, 5 to 9 of liquoric root, 5 to 15 of immature bitter orange, 5 to 15 of Chinese gooseberry, 5 to 15 of radish seed, 10 to 20 of chicken's gizzard-membrane, 15 to 25 of artemisia capillaris, 5 to 15 of windpipe trachea, 5 to 15 of galanga galangal seed, etc. by weight. the present invention uses the conventional preparation technique, and the dosage form of the present invention comprises the medicinal powder, the medicinal broth, the pill, the paste, the medicinal wine and the soluble preparation in the traditional Chinese pharmacology and is preferably the medicinal powder, the watered pill or the medicinal broth.

Description

A kind of medicine for the treatment of hepatopathy
Affiliated technical field
The present invention relates to a kind of Chinese herbal and crude drugs preparations, the particularly a kind of multiple liver of effect spirit that can treat hepatitis looses.
Background technology
At present, the medicament categories of the various hepatitis of known treatment is a lot, and Chinese medicine, Western medicine all have, and these medicines have generally all played certain effect to treatment hepatitis, and the state of an illness that makes that has has obtained containment, develops toward the good aspect, and what have has stablized the state of an illness.But generally speaking, imprecise though most drug has certain curative effect, easily bounce-back, unsatisfactory, cure rate is low, and also has certain side effect.
Summary of the invention
1, the technical problem that will solve
The present invention cuts in order to overcome and to solve existing Chinese and western drugs uncertain therapeutic efficacy for the treatment of hepatitis, the deficiency that cure rate is low, and provide a kind of treatment hepatitis clinical effectiveness good, stable curative effect, the definite multiple liver of effect spirit loose.
2, technical scheme
The technical solution adopted in the present invention is to realize like this, a kind of pharmaceutical composition for the treatment of hepatitis-multiple liver of effect spirit looses, so its special character is being made by following quality proportion raw material: Radix Bupleuri 10-20, Flos Wikstroemiae Dolichanthae 5-15, Radix Paeoniae Rubra 10-20, Resina Ferulae 4-8, Pericarpium Citri Reticulatae Viride 5-15, show aunt 6-12, Cortex Magnoliae Officinalis 10-20 rhizoma sparganic 10-20, Rhizoma Curcumae 5-15, Fructus Tsaoko 10-20, Radix Pseudostellariae 10-20, Rhizoma Atractylodis Macrocephalae 10-20, Poria 10-20, Radix Aucklandiae (Radix Vladimiriae) 3-7, Radix Curcumae 10-20, Pericarpium Arecae 15-25, Hirudo 5-15, Fructus Aurantii Immaturus 5-15, Carapax Trionycis (processed with vinegar) 10-20, Radix Angelicae Sinensis 5-15, Ganoderma 2-4, Herba Lobeliae Chinensis 15-30, Flos Carthami 3-9, Radix Glycyrrhizae 5-9, carambola 5-15, Semen Raphani 5-15, Endothelium Corneum Gigeriae Galli 10-20, Herba Artemisiae Scopariae 15-25, Rhizoma Paridis 5-15 and Fructus Galangae 5-15.
Realize that a kind of better mode of the present invention is, it is made by following quality proportioning raw material: Radix Bupleuri 12-18, Flos Wikstroemiae Dolichanthae 7-13, Radix Paeoniae Rubra 12-18, Resina Ferulae 5-7, Pericarpium Citri Reticulatae Viride 7-13, show aunt 8-10, Cortex Magnoliae Officinalis 12-18, rhizoma sparganic 12-18, Rhizoma Curcumae 7-13, Fructus Tsaoko 12-18, Radix Pseudostellariae 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Poria 12-18, Radix Aucklandiae (Radix Vladimiriae) 4-6, Radix Curcumae 12-18, Carapax Trionycis (processed with vinegar) 12-18 Hirudo 7-13, Fructus Aurantii Immaturus 4-13, Pericarpium Arecae 17-23, Radix Angelicae Sinensis 7-13, Ganoderma 3, Flos Carthami 5-7, Radix Glycyrrhizae 6-8, Herba Lobeliae Chinensis 18-27, carambola 7-13, Semen Raphani 7-13, Endothelium Corneum Gigeriae Galli 12-18, Herba Artemisiae Scopariae 17-23, Rhizoma Paridis 7-13 and Fructus Galangae 7-13.
Realize that a kind of Cui mode of the present invention is that it is made by following quality proportion raw material: Radix Bupleuri 15g, Flos Wikstroemiae Dolichanthae 10g, Radix Paeoniae Rubra 15g, Resina Ferulae 6g, Pericarpium Citri Reticulatae Viride 10g, show aunt 8g, Cortex Magnoliae Officinalis 15g, rhizoma sparganic 10g, Rhizoma Curcumae 10g, Fructus Tsaoko 15g, Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 15g, Poria 15g, Radix Aucklandiae (Radix Vladimiriae) 5g, Radix Curcumae 12g, Pericarpium Arecae 20g, Hirudo 10g, Carapax Trionycis (processed with vinegar) 15g, Fructus Aurantii Immaturus 6g, Radix Angelicae Sinensis 10g, Ganoderma 3g, Herba Lobeliae Chinensis 20g, Flos Carthami 6g, Radix Glycyrrhizae 6g, carambola 10g, Semen Raphani 10g, Endothelium Corneum Gigeriae Galli 10g, Herba Artemisiae Scopariae 20g, Rhizoma Paridis 10g and Fructus Galangae 10g.
The present invention is that a kind of pharmaceutical composition-multiple liver of effect spirit for the treatment of hepatitis looses, and its dosage form is said powder, decoction, pill, unguentum, medicated wine or a granule or powder preparation to be taken after being infused in boiling water in the Chinese materia medica, is preferably powder, decoction or the watered pill.The general seriously ill decoction of using, stable disease is with the powder or the watered pill.
The present invention is that a kind of pharmaceutical composition-multiple liver of effect spirit for the treatment of hepatitis looses, the preparation technology of its watered pill is with Flos Wikstroemiae Dolichanthae, Radix Paeoniae Rubra, Resina Ferulae, shows raw materials such as aunt, rhizoma sparganic, Rhizoma Curcumae, Fructus Tsaoko, Radix Pseudostellariae, Radix Aucklandiae (Radix Vladimiriae), Radix Curcumae, Pericarpium Arecae, Hirudo, Carapax Trionycis (processed with vinegar), Fructus Aurantii Immaturus, Radix Angelicae Sinensis, Ganoderma, Herba Lobeliae Chinensis, Flos Carthami, Radix Glycyrrhizae, carambola, Semen Raphani, Endothelium Corneum Gigeriae Galli, Herba Artemisiae Scopariae, Rhizoma Paridis and Fructus Galangae, process Back mixing for standby use; Cortex Magnoliae Officinalis, Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Poria, the Rhizoma Atractylodis Macrocephalae are added 2-3 times of drinking water decoct three times, it is stand-by that the merging decoction liquor is equivalent to 2 times of amounts of its crude drug.Decoction liquor is a wetting agent, behind the pill mould, continues to add the watered pill that the decoction liquid flooding becomes required size.Per 100 the heavily about 10g of the watered pill; Packing 50g/ bottle.
Instructions of taking: each 8-10g, every day 3 times, the Fructus Jujubae mixing in water for oral taking, be 3 months per course of treatment.
The present invention is applicable to viral hepatitis, drug induced hepatitis, fatty liver, hepatitis interstitialis chronica, hepatic ascites and early stage liver neoplasm etc.The present invention has that QI and blood two is transferred, the characteristics of reinforcement and elimination in combination, melts depressed liver-energy dispersing and QI regulating, invigorating the spleen and regulating the stomach, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, dampness removing and reduces phlegm and be one.Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Radix Curcumae, the Rhizoma Atractylodis Macrocephalae, the Radix Aucklandiae, Endothelium Corneum Gigeriae Galli, Fructus Aurantii Immaturus, Semen Raphani, Resina Ferulae, Cortex Magnoliae Officinalis, Radix Pseudostellariae, Radix Glycyrrhizae dispersing the stagnated live-QI to relieve the stagnation of QI, QI invigorating function of gallbladder promoting, promoting the circulation of QI to relieve pain, invigorating the spleen and regulating the stomach in the side meet the disease Therapeutic Principle of real liver in the ban who sees liver; Show that invigorate blood circulation, the eliminate the phlegm blood stasis dispelling, dispelling the stagnated QI promoting the circulation of blood, removing food stagnancy of aunt, Radix Paeoniae Rubra, Hirudo, rhizoma sparganic, Rhizoma Curcumae, Flos Carthami, Chinese angelica blood supplementing removes painful abdominal mass; Enzyme falls in Flos Wikstroemiae Dolichanthae, Fructus Tsaoko, Poria, Fructus Galangae, Herba Artemisiae Scopariae, Fructus actinidiae chinensis, Pericarpium Arecae, Rhizoma Paridis, Herba Lobeliae Chinensis diuretic dampness, heat-clearing and toxic substances removing, removing heat from blood quench the thirst, reduce phlegm jaundice eliminating, hepatoprotective, and the broad-spectrum antivirus action is arranged; Carapax Trionycis (processed with vinegar) nourishing YIN for suppressing the hyperactive YANG, Ganoderma nourishes strong shape.All medicines share, and reinforcing body resistance improves the liver blood circulation, improve cell immunocompetent, promote liver cell regeneration, repair liver tissue injury, recover liver function, suppress hepatic fibroplasia, promote fiber absorbs, reduce hepatic necrosis, prevent steatosis, the retraction hepatosplenomegaly helps having a liking for the removing of hepatovirus, immune complex and pathometabolism thing.
The specific embodiment
The present invention is further described below in conjunction with embodiment
Embodiment 1, takes by weighing: Radix Bupleuri 15g, Flos Wikstroemiae Dolichanthae 10g, Radix Paeoniae Rubra 15g, Resina Ferulae 6g, Pericarpium Citri Reticulatae Viride 10g, show aunt 8g, Cortex Magnoliae Officinalis 15g, rhizoma sparganic 10g, Rhizoma Curcumae 10g, Fructus Tsaoko 15g, Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 15g, Poria 15g, Radix Aucklandiae (Radix Vladimiriae) 5g, Radix Curcumae 12g, Pericarpium Arecae 20g, Hirudo 10g, Carapax Trionycis (processed with vinegar) 15g, Fructus Aurantii Immaturus 6g, Radix Angelicae Sinensis 10g, Ganoderma 3g, Herba Lobeliae Chinensis 20g, Flos Carthami 6g, Radix Glycyrrhizae 6g, carambola 10g, Semen Raphani 10g, Endothelium Corneum Gigeriae Galli 10g, Herba Artemisiae Scopariae 20g, Rhizoma Paridis 10g and Fructus Galangae 10g.Technology is made powder routinely.
Embodiment 2, take by weighing: Radix Bupleuri 18g, Flos Wikstroemiae Dolichanthae 13g, Radix Paeoniae Rubra 12g, Resina Ferulae 7g, Pericarpium Citri Reticulatae Viride 13g, show aunt 9g, Cortex Magnoliae Officinalis 18g, rhizoma sparganic 12g, Rhizoma Curcumae 9g, Fructus Tsaoko 12g, Radix Pseudostellariae 12g, Rhizoma Atractylodis Macrocephalae 18g, Poria 18g, Radix Aucklandiae (Radix Vladimiriae) 4g, Radix Curcumae 15g, Pericarpium Arecae 18g, Carapax Trionycis (processed with vinegar) 12g, Hirudo 8g, Fructus Aurantii Immaturus 8g, Radix Angelicae Sinensis 12g, Ganoderma 3g, Herba Lobeliae Chinensis 18g, Flos Carthami 6g, Radix Glycyrrhizae 6g, carambola 15g, Semen Raphani 15g, Endothelium Corneum Gigeriae Galli 18g, Herba Artemisiae Scopariae 25g, Rhizoma Paridis 12g and Fructus Galangae 12g.Make decoction after technology decocts routinely.
Embodiment 3, take by weighing: Radix Bupleuri 10g, Flos Wikstroemiae Dolichanthae 8g, g Radix Paeoniae Rubra 10g, Resina Ferulae 5g, cream skin 8g, show aunt 10g, Cortex Magnoliae Officinalis 10g, rhizoma sparganic 15g, Rhizoma Curcumae 8g, Fructus Tsaoko 10g, Radix Pseudostellariae 10g, Rhizoma Atractylodis Macrocephalae 10g, Poria 10g, Radix Aucklandiae (Radix Vladimiriae) 6g, Radix Curcumae 10g, Pericarpium Arecae 15g, Carapax Trionycis (processed with vinegar) 10g, Hirudo 5g, Fructus Aurantii Immaturus 10g, Radix Angelicae Sinensis 8g, Ganoderma 3g, Herba Lobeliae Chinensis 22g, Flos Carthami 8g, Radix Glycyrrhizae 8g, carambola 12g, Semen Raphani 12g, Endothelium Corneum Gigeriae Galli 12g, Herba Artemisiae Scopariae 22g, Rhizoma Paridis 15g and Fructus Galangae 15g.Above-mentioned raw materials is passed through
Figure C20041005472100051
Back mixing for standby use; Cortex Magnoliae Officinalis, Radix Bupleuri, Pericarpium Citri Reticulatae Viride, Poria, the Rhizoma Atractylodis Macrocephalae are added 2-3 times of drinking water decoct three times, it is stand-by that the merging decoction liquor is equivalent to 2 times of amounts of its crude drug.Decoction liquor is a wetting agent, behind the pill mould, continues to add the watered pill that the decoction liquid flooding becomes required size.Per 100 the heavily about 10g of the watered pill; Packing 50g/ bottle.
Imitating the multiple liver of spirit looses
The clinical observation on the therapeutic effect report
Imitate the curative effect that the multiple liver of spirit looses in order to verify, be subjected to inventor Mr.'s Yin Guisen trust, my institute ended since year May in January, 2002 to 2004, successively lasted 2 years 5 months again, test imitating the diffusing clinical observation on the therapeutic effect that carries out of the multiple liver of spirit, now clinical test results be reported as follows:
One, clinical data
Imitate the diffusing liver's illness such as viral hepatitis, fatty liver, alcoholic hepatitis, drug induced hepatitis, liver cirrhosis, hepatic ascites and early stage cancer that are used for the treatment of of the multiple liver of spirit.My institute has mainly carried out clinical observation on the therapeutic effect to the patient who suffers from viral hepatitis, liver cirrhosis, hepatic ascites.Methods for clinical diagnosis is undertaken by the viral hepatitis diagnostic criteria of nineteen ninety-five Beijing the 5th whole nation infectious disease parasite association discussion revision.
(1) case arrangement
Convincing in order to test, the hepatitis that will come to go to a doctor is divided into two groups at random, i.e. test group and matched group.Again in 5 months, successively accepted 203 routine patients at these 2 years altogether for medical treatment, be grouped as follows:
(1) test group: 128 people, wherein: male 70 people, women 58 people, discontented 18 years old 12 people, 18-40 the year 66 people, 41-60 year 41 people, 9 people more than 61 years old.
(2) matched group: 75 people, wherein: male 43 people, women 32 people, discontented 18 years old 8 people, 18-40 the year 32 people, 41-60 the year 29 people, 6 people more than 60 years old.
(2) clinical symptoms by stages
1. viral hepatitis
(1) acute stage:
1. acute icterohepatitis type: inappetence, nausea and vomiting, detest oil, abdominal distention diarrhoea, percussion tenderness over hepatic region, the intensification of urine color, sclera and xanthochromia, hepatomegaly etc.
2. do not have the jaundice type: except that no jaundice, all the other symptoms are similar but lighter to the jaundice type.
(2) chronic phase:
1. chronic persisting type: patients acuity morbidity back protracted course of disease, the course of disease surpasses half a year, still has hepatitis symptom in various degree.
2. chronic active type: be more common in hepatitis B, the course of disease surpassed more than 1 year, still had hepatitis symptom.
(3) convalescent period: jaundice and other symptoms disappear gradually.Appetite is promoted, and muscle power is also recovered gradually, and hepatalgia disappears, and the liver spleen of enlargement bounces back gradually, and liver function is recovered gradually.
(4) serious symptom: mean acute severe hepatitis and subacute severe hepatitis.
2. liver cirrhosis:
(1) the compensatory phase: symptom is not obvious clinically, only slight dyspepsia, and Signs is mainly hepatomegaly.
(2) lose the compensatory phase: whole body becomes thin, weak; Poor appetite, abdominal distention diarrhoea; Spider angioma, liver palm, cutaneous pigmentation; Liver, spleen enlargement, liver hardening etc.
This mainly to acute stage, chronic phase and convalescent period hepatitis and liver cirrhosis patient carry out clinical observation on the therapeutic effect.
Two, Therapeutic Method
(1) test group: oral Mr.'s Yin Guisen of this group group patient the multiple liver of effect spirit looses, every day 3 times, each 6-10g, taking medicine after meal.The left alone without help Chinese and western drugs of period in a medicine with other treatment hepatitis.
(2) matched group: this group patient adopts vitaminize c in quiet 10% glucose injection, Energy mixture, oral conventional hepatic (compound liver-benepitino remedy, glucuronolatone, compound vitamin B) treatment, and awards support, symptomatic treatment.
All case is not all used antiviral drugs and immunomodulator, but has all adopted trophotherapy in medication, to strengthen curative effect, is a course of treatment with three months.
Three. observation index
Clinical symptoms before and after two groups of patient's medications of O﹠E, Signs are improved situation,, jaundice little and liver function etc. as appetite, abdominal distention, hepatalgia, hepatosplenomegaly, and by Type B ultrasonic and lab testing is judged every group curative effect situation.After above-mentioned data are handled with the medical statistics method, its result such as following table:
Clinical observation observation index information slip
Clinical stages The example number Clinical symptoms Type B is ultrasonic Antigen-antibody
Take a turn for the better Do not have and change Increase the weight of Take a turn for the better Do not have and change Increase the weight of Take a turn for the better Do not have and change Increase the weight of
Test group Acute 26 25 1 25 1 25 1
Chronic 79 73 6 70 9 65 14
Recover 23 21 2 21 2 20 3
Subtotal 128 119 9 116 12 110 18
Matched group Acute 23 21 2 21 2 21 2
Chronic 41 30 11 30 11 25 16
Recover 11 9 2 9 2 9 2
Subtotal 75 60 15 60 15 55 20
Four. curative effect judging standard
Carry out according to the chronic hepatitis curative effect judging standard of drafting in the Ministry of Public Health " clinical drug research guideline ".
1. produce effects: subjective symptoms disappears, and hepatosplenomegaly is constant or dwindle, no tenderness, and the hepatic region does not have percussion pain, and liver function recovery is normal, and the hepatitis B patient partial antibody is turned out cloudy.
2. effective: subjective symptoms disappears or basic the disappearance, and hepatosplenomegaly is stablized constant, does not have obviously pain, and the hepatic region does not have the pain of obviously kowtowing, and liver function recovery is normal or than the initial value 50% above person that descends.
3. invalid: subjective symptoms and liver function do not have obvious improvement.
Five. the result
1. comprehensive therapeutic effect: two groups of patients through a course of therapy after, its comprehensive therapeutic effect situation is added up by the medicostatistics method, comparing result is as follows:
Comprehensive therapeutic effect situation contrast statistical table
The example number Produce effects Effectively Invalid Total effective rate
The example number The example number The example number The example number
Test group 128 36 28 83 65 9 7 119 93
Matched group 75 20 27 40 53 15 20 60 80
2, clinical symptoms
Clinical symptoms improvement situation contrast statistical table
Abdominal distention Hepatalgia Hepatomegaly Splenomegaly
The example number The example number The example number The example number
Test group 128 128 100 101 79 110 86 80 63
Matched group 75 75 100 58 77 54 72 53 71
Find out that through statistics test group total effective rate aspect Comprehensive Treatment is 93%, and the total effective rate of matched group is 80%, the test group comprehensive therapeutic effect is apparently higher than matched group.Aspect clinical Signs improved, abdominal distention, hepatalgia, hepatomegaly and splenomegaly, test group were all significantly better than matched group.Clinical trial proves, the multiple liver of effect spirit of Mr.'s Yin Guisen treatment hepatitis looses, reasonable recipe, and determined curative effect is better than general conventional medicine, is a kind of new drug of treatment hepatitis with practical value.
Case is given an example:
Example 1, patient's Japanese plum spring man 52 years old live traction therapy town, Jiaohe City, Jilin Province, on May 15th, 2003, because of upper right abdominal distention and pain at Jilin infectious hospital hospitalization, be diagnosed as hepatitis B, be in hospital 2 months, due to illness feelings do not take a turn for the better and increase the weight of on the contrary, and July 21, the Nikkei people introduced institute to seek medical advice.Check through the court: golden body skin, yellow sclera, upper right ventral tubercle, the obvious edema of lower limb, hepatosplenomegaly, tenderness, liver palm.Main suit: abdominal distention, weak, hepatalgia, loss of appetite.Lab testing: HBsAg in serum, HBeAg and anti--HBcIgM are positive, and are diagnosed as chronic viral hepatitis B, cirrhotic ascites.Through agreeing through the patient, the multiple liver of effect spirit that begins to take Mr. Yin Guisen looses administration 10 staggering amounts.10 days institutes afterwards, private prosecution appetite increases to some extent, hepatalgia alleviates to some extent, gives the medicine of opening a month amount again, advises its medication according to quantity on time, should suitably have a rest, and diet suitably replenishes a little protein, saccharide and vitamin etc. with light agreeable to the taste being advisable.A month institute afterwards, abdominal distention obviously alleviates, hepatalgia stops, more competent light work, mental status Cui.These prove that this medicine suits the medicine to the illness, and continue medication 2 courses of treatment of institute afterwards again, and through ultrasound diagnosis: hepatosplenomegaly disappears; Lab testing: liver function recovery is normal; Three pairs of inspections: HBeAg turns out cloudy, and the clinical Signs of private prosecution disappears.Advise it to continue 3 courses of treatment of medication again, follow up a case by regular visits to, fully recover.So far do not have bounce-back.
Example 2,
Zhang Huairen, 43 years old laid-off worker of man, in JIUYUE, 2002 is chronic viral hepatitis B by Jilin second hospital diagnosis, and is invalid through multi-treatment.On March 3rd, 2003 was come institute, and disease is seen: limbs are weak, can reach 2cm under the uncomfortable liver area, abdominal distention, hepatosplenomegaly, rib, and matter is tough, light tenderness.Examine and be chronic viral hepatitis B, take Mr.'s Yin Guisen " imitating the multiple liver of spirit looses " 1 month, come institute, clinical Signs is clearly better, appetite increases, conscious health had had strength than in the past.Continue administration 2 months again, the shared medicine in front and back 3 months.Subjective symptoms disappears, and can participate in some work in power, and lab testing: liver function is normal, and ascites disappears.The back stops treatment because of hard up.Phone is followed up a case by regular visits to after half a year, not yet recurrence.(east, Jilin hospital)

Claims (5)

1. medicine for the treatment of hepatopathy is characterized in that it is made by following quality proportion raw material: Radix Bupleuri 10-20, Flos Wikstroemiae Dolichanthae 5-15, Radix Paeoniae Rubra 10-20, Resina Ferulae 4-8, Pericarpium Citri Reticulatae Viride 5-15, Rhizoma Pinelliae 6-12, Cortex Magnoliae Officinalis 10-20, rhizoma sparganic 10-20, Rhizoma Curcumae 5-15, Fructus Tsaoko 10-20, Radix Pseudostellariae 10-20, Rhizoma Atractylodis Macrocephalae 10-20, Poria 10-20, Radix Aucklandiae (Radix Vladimiriae) 3-7, Radix Curcumae 10-20, Pericarpium Arecae 15-25, Hirudo 5-15, Fructus Aurantii Immaturus 5-15, Carapax Trionycis (processed with vinegar) 10-20, Radix Angelicae Sinensis 5-15, Ganoderma 2-4, Herba Lobeliae Chinensis 15-30, Flos Carthami 3-9, Radix Glycyrrhizae 5-9, Fructus actinidiae chinensis 5-15, Semen Raphani 5-15, Endothelium Corneum Gigeriae Galli 10-20, Herba Artemisiae Scopariae 15-25, Rhizoma Paridis 5-15 and Fructus Galangae 5-15.
2. a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that it is made by following quality proportion raw material: Radix Bupleuri 12-18, Flos Wikstroemiae Dolichanthae 7-13, Radix Paeoniae Rubra 12-18, Resina Ferulae 5-7, Pericarpium Citri Reticulatae Viride 7-13, Rhizoma Pinelliae 8-10, Cortex Magnoliae Officinalis 12-18, rhizoma sparganic 12-18, Rhizoma Curcumae 7-13, Fructus Tsaoko 12-18, Radix Pseudostellariae 12-18, Rhizoma Atractylodis Macrocephalae 12-18, Poria 12-18, Radix Aucklandiae (Radix Vladimiriae) 4-6, Radix Curcumae 12-18, Pericarpium Arecae 17-23, Carapax Trionycis (processed with vinegar) 12-18, Hirudo 7-13, Radix Angelicae Sinensis 7-13, Ganoderma 3, Herba Lobeliae Chinensis 18-27, Flos Carthami 5-7, Radix Glycyrrhizae 6-8, Fructus Aurantii Immaturus 4-13, Fructus actinidiae chinensis 7-13, Semen Raphani 7-13, Endothelium Corneum Gigeriae Galli 12-18, Herba Artemisiae Scopariae 17-23, Rhizoma Paridis 7-13 and Fructus Galangae 7-13.
3. a kind of medicine for the treatment of hepatopathy according to claim 1 and 2 is characterized in that it is made by following quality proportion raw material: Radix Bupleuri 15g, Flos Wikstroemiae Dolichanthae 10g, Radix Paeoniae Rubra 15g, Resina Ferulae 6g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Pinelliae 8g, Cortex Magnoliae Officinalis 15g, rhizoma sparganic 10g, Rhizoma Curcumae 10g, Fructus Tsaoko 15g, Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 15g, Poria 15g, Radix Aucklandiae (Radix Vladimiriae) 5g, Radix Curcumae 12g, Pericarpium Arecae 20g, Carapax Trionycis (processed with vinegar) 15g, Hirudo 10g, Fructus Aurantii Immaturus 6g, Radix Angelicae Sinensis 10g, Ganoderma 3g, Herba Lobeliae Chinensis 20g, Flos Carthami 6g, Radix Glycyrrhizae 6g, Fructus actinidiae chinensis 10g, Semen Raphani 10g, Endothelium Corneum Gigeriae Galli 10g, Herba Artemisiae Scopariae 20g, Rhizoma Paridis 10g and Fructus Galangae 10g.
4. a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that being that its dosage form is said powder, decoction, pill, unguentum, medicated wine or a granule or powder preparation to be taken after being infused in boiling water in the Chinese materia medica.
5. a kind of medicine for the treatment of hepatopathy according to claim 4 is characterized in that its dosage form is powder, the watered pill or decoction.
CNB2004100547217A 2004-07-16 2004-07-16 Medicine for treating liver disease Expired - Fee Related CN1294980C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100547217A CN1294980C (en) 2004-07-16 2004-07-16 Medicine for treating liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100547217A CN1294980C (en) 2004-07-16 2004-07-16 Medicine for treating liver disease

Publications (2)

Publication Number Publication Date
CN1586512A CN1586512A (en) 2005-03-02
CN1294980C true CN1294980C (en) 2007-01-17

Family

ID=34603127

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100547217A Expired - Fee Related CN1294980C (en) 2004-07-16 2004-07-16 Medicine for treating liver disease

Country Status (1)

Country Link
CN (1) CN1294980C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101385823B (en) * 2008-10-23 2011-04-27 上海方心科技研究所 Medicine for treating heavy acute pancreatitis and preparation method thereof
CN102327411A (en) * 2011-10-10 2012-01-25 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic gastroparalysis
CN103861043A (en) * 2014-03-27 2014-06-18 王旋旋 External medicament of traditional Chinese medicine for treating liver cirrhosis
CN104027735A (en) * 2014-06-16 2014-09-10 王素玲 Traditional Chinese medicinal composition used for treating cirrhosis and preparation method thereof
CN106110274B (en) * 2016-08-18 2019-08-30 陈定潜 It is a kind of for treating the Chinese medicine composition and preparation method thereof of chronic viral hepatitis or hepatic failure

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421234A (en) * 2002-12-13 2003-06-04 郭言勋 Oral liquid for treating hepatitis B

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1421234A (en) * 2002-12-13 2003-06-04 郭言勋 Oral liquid for treating hepatitis B

Also Published As

Publication number Publication date
CN1586512A (en) 2005-03-02

Similar Documents

Publication Publication Date Title
CN1044974C (en) Anti- hepatitis B preparation
US6911221B2 (en) Anti-neoplastic drug
CN101390994B (en) Medicine for treating herpes zoster
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN112891399A (en) Traditional Chinese medicine composition and application and preparation method thereof
CN1895619A (en) Chinese-medicinal composition for preventing and treating liver disease and its preparation
CN1294980C (en) Medicine for treating liver disease
CN101940759B (en) Chinese medicinal composition for treating liver diseases and preparation method and application thereof
CN1149097C (en) Chinese patent medicine for curing diabetes
CN1223374C (en) Chinese medicinal composition for treating hepatitis B
CN1063954C (en) Chinese patent medicine-powder preparation for curing hepatitis B
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN1052889C (en) Chinese proprietary for curing hepatitis
CN101940758B (en) Traditional Chinese medicinal composition for treating liver diseases, preparation method thereof and application thereof
CN1319587C (en) Medicine powder for liver and spleen diseases
CN1094057C (en) Liver ascites treating medicine
CN1195541C (en) Medicine combination for treating chronic hepatitis B
CN1176690C (en) Medicine for treating chronic nephritis
CN103611035A (en) Traditional Chinese medicine composition for treating phlegm-dampness stagnation type fatty liver
CN103341094B (en) Preparation method of powder for treating vulva squamous epithelial cell hyperplasia
CN103330867A (en) Preparation method of powder for treating senile vaginitis
CN1159054C (en) Tongfuzhixie preparation
CN116350731B (en) Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof
CN1481876A (en) Medication for virus hepatitis and hepatocirrhosis
CN1101559A (en) Traditional Chinese medicine oral administration liquid for anti-cancer and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee